C62.92
C62.92 — Malignant neoplasm of left testis, unspecified whether descended or undescended
Billable / specific codeICD-10-CMleft
C62.92 is a billable, specific ICD-10-CM code for malignant neoplasm of left testis, unspecified whether descended or undescended. It is valid for submission on a claim.
Risk adjustment
C62.92 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 23 Prostate, Breast, and Other Cancers and Tumors0.186 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C62.92 is named in 40 Medicare coverage policies — 40 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C62.9. If C62.92 is not quite right, the correct code is usually one of these.
Questions about C62.92
- Is C62.92 a billable ICD-10-CM code?
- Yes. C62.92 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C62.92 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of male genital organs (C60-C63).